PERRY CAIN: Open Payments
NPI 1649257528 · PHILA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 28 payments from 4 companies in 2025. Trend: 2023 $203 · 2024 $828 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 22 | $231 |
| AstraZeneca Pharmaceuticals LP | 3 | $142 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
Products named: WATCHMAN FLX, LOKELMA, JARDIANCE, AREXVY, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
